PHARMACIE DE LA BADIANE : revenue, balance sheet and financial ratios

PHARMACIE DE LA BADIANE is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PFASTATT (68120), this company of category PME shows in 2020 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA BADIANE (SIREN 834721532)
Indicator 2023 2022 2021 2020 2019
Revenue N/C N/C N/C 1 880 016 € 2 333 745 €
Net income 108 909 € 193 166 € 112 354 € 93 580 € 90 125 €
EBITDA N/C N/C N/C 141 099 € 210 255 €
Net margin N/C N/C N/C 5.0% 3.9%

Revenue and income statement

In 2023, PHARMACIE DE LA BADIANE generates positive net income of 109 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 90 k€ -> 109 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

108 909 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 275%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

274.899%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

24.036%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

69.6%

Solvency indicators evolution
PHARMACIE DE LA BADIANE

Sector positioning

Debt ratio
274.9 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average

In 2023, the debt ratio of PHARMACIE DE LA BADIANE (274.90) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
24.04% 2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Average

In 2023, the financial autonomy of PHARMACIE DE LA BADIANE (24.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 159.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

159.114

Liquidity indicators evolution
PHARMACIE DE LA BADIANE

Sector positioning

Liquidity ratio
159.11 2023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Average +7 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE DE LA BADIANE (159.11) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 276 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 744 days. Excellent situation: suppliers finance 468 days of the operating cycle (retail model).

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

276 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

744 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE LA BADIANE

Positioning of PHARMACIE DE LA BADIANE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE DE LA BADIANE is estimated at 1 285 069 € (range 781 512€ - 1 806 518€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
781k€ 1285k€ 1806k€
1 285 069 € Range: 781 512€ - 1 806 518€
NAF 5 année 2023

Valuation method used

Net Income Multiple
108 909 € × 11.8x = 1 285 069 €
Range: 781 512€ - 1 806 519€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA BADIANE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA BADIANE

What is the revenue of PHARMACIE DE LA BADIANE ?

The revenue of PHARMACIE DE LA BADIANE in 2020 is 1.9 M€.

Is PHARMACIE DE LA BADIANE profitable?

Yes, PHARMACIE DE LA BADIANE generated a net profit of 109 k€ in 2023.

Where is the headquarters of PHARMACIE DE LA BADIANE ?

The headquarters of PHARMACIE DE LA BADIANE is located in PFASTATT (68120), in the department Haut-Rhin.

Where to find the tax return of PHARMACIE DE LA BADIANE ?

The tax return of PHARMACIE DE LA BADIANE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA BADIANE operate?

PHARMACIE DE LA BADIANE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.